Wal-Mart (WMT) plans a significant expansion of its programs to bring inexpensive prescription drugs to its customers which will almost certainly damage margins as its competitors. According to The Wall Street Journal, “The discount retailer…
There was an interesting twist in the ongoing Dendreon Corp. (NASDAQ: DNDN) story that developed after 5:00 PM Friday. There was a whole series of FORM 4 filings insider sales filings with the SEC. …
Sequenom, Inc. (NASDAQ: SQNM) is trading higher today after the huge implosion yesterday. With a short interest of close to 30% of its whole float and with day traders and bottom-fishers getting in the…
SEQUENOM, Inc. (NASDAQ: SQNM) looks like the newest implosion of a hopeful company. The company was supposed to have the Holy Grail for detection of Down syndrome. After yesterday’s close, the company announced that…
This week there have been many crazy stock gains among the speculative biotech sector, and these were tied directly to the ‘speculative stocks’ that could have any ties in reality, fiction, and even imagination…
Dendreon Corp. (NASDAQ: DNDN) has already been all over the news with its positive PROVENGE data for the submission of an FDA application now looking likely late in 2009 with the hopes of a…
Story UPDATED at 3:10 EST: 15:05:01 EST NASDAQ has reviewed the transactions under rule 11890 (b) on its own motion filing involving the security Dendreon Corp. (NASDAQ: DNDN) executed between 13:25:00 and 13:27:02 ET…
Dendreon Corporation (NASDAQ: DNDN) was halted today at 13:27:02 ahead of the data embargo due at 2:00 PM EST. The data for its key Phase III IMPACT study for PROVENGE as a last line…
The Tickerspy index of swine flu and bird flu stocks is up 21% as the market nears its close. The index is being pushed higher by share in Biocryst Pharma (BRCX), which is up…
Using stock options in Dendreon Corp. (NASDAQ: DNDN) shows that the expectations of major price moves have not let up, and the company’s stock is trading up yet again ahead of the data due…
You have probably heard more and more about the swine flu epidemic from Mexico spreading to the U.S., and a new media advisory is confirming that the drugs Tamiflu by Roche (OTC: RHHBY) and…
Amgen Inc. (NASDAQ: AMGN) has posted some very highly anticipated and uninteresting earnings. The biotech giant reported $0.98 EPS net and $1.08 non-GAAP EPS on $3.31 billion in revenue, while Thomson Reuters had estimates…
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual meeting, and some traders…
Dendreon Corporation (NASDAQ: DNDN) has announced that its pivotal Phase 3 IMPACT study of PROVENGE in men with advanced prostate cancer data. While the data is incomplete, Dendreon said that the IMPACT study met…
About two years ago, GE (GE) began to talk about its “green” initiative and how important it was that businesses and governments begin to work on sustainable energy solutions to save the environment. Of…